Abstract:
The present disclosure relates to methods and systems for providing a multimodal 3D object interaction to let the user interact with 3D digital object in a natural and realistic way.
Abstract:
A membrane reactor used for electrochemically converting a carbon dioxide gas into an expected product includes a cavity, a solid electrolyte membrane separator, a cathode, an anode, and a fuel cell. The solid electrolyte membrane separator is disposed in the cavity and divides the cavity into two chambers defined as a cathode chamber and an anode chamber. The cathode is disposed in the cathode chamber, and the anode is disposed in the anode chamber. The fuel cell is disposed outside the cavity to provide an electrolytic voltage. The fuel cell includes a fuel inlet, an oxidant inlet, and a reaction product outlet. The expected product includes a hydrogen gas and an oxygen gas. The hydrogen gas used as a fuel is fed in the fuel inlet, and the oxygen gas used as an oxidant is fed in the oxidant inlet for the fuel cell to produce electrical power.
Abstract:
A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
Abstract:
A membrane electrode includes a first electrode, a second electrode, and a proton exchange membrane sandwiched between the first electrode and the second electrode. The first electrode includes a first gas diffusion layer and a first catalyst layer. The second electrode includes a second gas diffusion layer and a second catalyst layer. The first catalyst layer or the second catalyst layer includes a carbon nanotube-metal particle composite including carbon nanotubes, polymer layer, and metal particles. The polymer layer is coated on a surface of the carbon nanotubes and defines a plurality of pores uniformly distributed; the metal particles are located in the pores. A fuel cell including the membrane electrode is also disclosed.
Abstract:
Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions comprising the histamine-3 receptor ligands, methods for using such compounds and compositions, and a process for preparing compounds within the scope of formula (I).
Abstract:
A coated article includes a substrate having on its surface a coating that includes a polymer selected from the group consisting of hydroxypropylcellulose, poly(2-ethyl-2-oxazoline) and mixtures of these, a surfactant, colloidal silica, and a crosslinker selected from the group consisting of water-soluble titanium salts and water-soluble or water-dispersible organic crosslinkers. The coating may be formed by applying a dispersion of the coating composition in a diluent to the substrate and subsequently drying the coated substrate to evaporate the diluent.
Abstract:
A membrane reactor used for electrochemically converting a carbon dioxide gas into an expected product includes a cavity, a solid electrolyte membrane separator, a cathode, an anode, and a fuel cell. The solid electrolyte membrane separator is disposed in the cavity and divides the cavity into two chambers defined as a cathode chamber and an anode chamber. The cathode is disposed in the cathode chamber, and the anode is disposed in the anode chamber. The fuel cell is disposed outside the cavity to provide an electrolytic voltage. The fuel cell includes a fuel inlet, an oxidant inlet, and a reaction product outlet. The expected product includes a hydrogen gas and an oxygen gas. The hydrogen gas used as a fuel is fed in the fuel inlet, and the oxygen gas used as an oxidant is fed in the oxidant inlet for the fuel cell to produce electrical power.
Abstract:
Macrocyclic pyrimidine compounds, compositions comprising such compounds, methods for making the compounds, and methods of treating and preventing the progression of diseases, conditions, and disorders using such compounds and compositions are described herein.
Abstract:
Compounds of formula (I) are useful in treating conditions or disorders prevented by or ameliorated by histamine-3 receptor ligands. Also disclosed are pharmaceutical compositions of compounds of formula (I), methods for using such compounds and compositions, and a process for preparing the compounds.
Abstract:
A printed circuit board includes a first signal via, a second signal via, and a first ground via. A distance between the first ground via and the first signal via is substantially equal to a distance between the first ground via and the second signal via.